cbdMD (NYSEAMERICAN:YCBD – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.67) earnings per share (EPS) for the quarter, reports. The business had revenue of $5.38 million for the quarter. cbdMD had a negative return on equity of 105.32% and a negative net margin of 96.96%. cbdMD Trading Up 6.3 […]
cbdMD, Inc. (NYSEAMERICAN:YCBD – Get Free Report) was the target of a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 275,700 shares, a growth of 20.4% from the September 15th total of 228,900 shares. Currently, 12.0% of the company’s shares are sold short. Based […]
cbdMD's proprietary broad spectrum blend is safe when consumed as a dietary supplement in doses up to 160 mg per day in a 70 kg (154 lb), says a new study published in Regulatory Toxicology and Pharmacology.